Education
About Us
Working with TipRanks
Follow Us
Glenn Muir Insider Profile
116 Followers
Glenn Muir, Director at Repligen, holds 36.62K shares in Repligen (Ticker: RGEN), holds 371.82K shares in Neuronetics (Ticker: STIM), holds 0.00 shares in G1 Therapeutics (Ticker: GTHX).
Profitable Transactions
5 out of 8 Profitable Transactions
Average Return
+114.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Glenn Muir holds in companies
Most Profitable Insider Trade
The most profitable trade made by Glenn Muir
Glenn Muir's Trading History
Repligen
Dec 17, 2025
Director
Uninformative Buy
87.92K
$6.13M
Lifeward
Dec 31, 2015
Director
Uninformative Buy
―
$4.14K
G1 Therapeutics
Sep 18, 2024
―
Uninformative Sell
―
$0.00
Neuronetics
Oct 22, 2025
Director
Uninformative Buy
―
$669.27K
Hologic
May 12, 2014
EVP & CFO
Informative Sell
1.21M
$61.04M
List of latest transactions for each holding click on a transaction to see Glenn Muir's performance on stock
You May Also Like
Glenn Muir insider profile FAQ
What is the percentage of profitable transactions made by Glenn Muir?
The percentage of profitable transactions made by Glenn Muir is 63%.
What is the average return per transaction made by Glenn Muir?
The average return per transaction made by Glenn Muir is 114.80%.
What stocks does Glenn Muir hold?
Glenn Muir holds: RGEN, LFWD, GTHX, STIM, HOLX stocks.
What was Glenn Muir’s latest transaction?
Glenn Muir latest transaction was an Uninformative Buy of $87.92K.
What was Glenn Muir's most profitable transaction?
Glenn Muir’s most profitable transaction was an Informative Buy of STIM stock on September 6, 2024. The return on the trade was 316.70%.
What is Glenn Muir's role in Repligen?
Glenn Muir's role in Repligen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.